Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2004
08/26/2004WO2004072286A1 Substance specific to human pd-1
08/26/2004WO2004072283A1 Antifreeze protein containing ice nucleating protein sequence
08/26/2004WO2004072241A2 Compositions and methods for cleaving iap
08/26/2004WO2004072240A2 Antiplasmin cleaving enzyme
08/26/2004WO2004072225A2 Transgenic fungi expressing bcl-2 and methods of using bcl-2 or portions thereof for improving biomass production, survival, longevity, stress resistance and pathogenicity of fungi
08/26/2004WO2004072107A1 Method of preparing protein as a soluble form in a cell-free protein synthesis system
08/26/2004WO2004072100A2 Nell peptide expression systems and bone formation activity of nell peptide
08/26/2004WO2004071414A2 Therapeutic anti-hcv (al9) compounds
08/26/2004WO2004057002A3 Production of heterologous glycosylated proteins in bryophyte cells
08/26/2004WO2004036257A3 Screening compound libraries using an optical fiber array device capable of simultaneously performing multiple functional assays
08/26/2004WO2004024747A3 High affinity monoclonal antibody for recognizing the estrogen receptor (er) and method for creating the antibody
08/26/2004WO2004011599A3 Polypeptide cleavage process
08/26/2004WO2004000207A3 Toxin-phage bacteriocide antibiotic and uses thereof
08/26/2004WO2003093411A3 Ice1, a regulator of cold induced transcriptome and freezing tolerance in plants
08/26/2004WO2003092602A3 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
08/26/2004WO2003055440A3 Compositions and methods for the treatement of immune related diseases
08/26/2004WO2003049525A3 Methods and materials for the production of organic products in cells of $i(candida) species
08/26/2004WO2002102320A3 Fce fusion proteins for treatment of allergy and asthma
08/26/2004WO2002085302A3 Methods of treating intestinal inflammation
08/26/2004US20040167317 for treating lymphocyte-related disorders using self-assembling molecular complex designated pre-pro-B cell growth stimulating factor (PPBSF); genetic engineering
08/26/2004US20040167074 Therapeutic applications of mFLINT polypeptides
08/26/2004US20040167065 human transferases and polynucleotides which identify and encode them; expression vectors, host cells, antibodies, agonists, and antagonists; diagnosing, treating, or preventing disorders associated with aberrant expression of the transferases
08/26/2004US20040166566 Novel promoter
08/26/2004US20040166562 has a reduced doubling time; for the production, expression and recovery of harvestable polypeptides, drug screening for metabolic activity, studying enteric disease and for use in a bio-artificial liver device
08/26/2004US20040166486 RNA three dimensional structure (pseudoknot) which stimulates/activates protein synthesis; enhancement of cell-free translation of heterologous polypeptides
08/26/2004US20040166141 Methods and devices for modulating the immune response
08/26/2004US20040166116 Polypeptides containing polymorphisms of the repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions
08/26/2004US20040166110 For multiple drug resistance cancer; purification of hemoatopoietic stem cells; diagnosis, therapy
08/26/2004US20040166109 Modulator polypeptide for regulation of intracellular endocytosis of amyloid precursor proteins; diagnosis and treatment of neurodegenerative disorders
08/26/2004US20040166105 Compositions and methods relating to breast specific genes and proteins
08/26/2004CA2555510A1 Antiplasmin cleaving enzyme
08/26/2004CA2515208A1 Nell peptide expression systems and bone formation activity of nell peptide
08/25/2004EP1449923A1 Novel formate dehydrogenase tolerant to halogen compounds and process for producing the same
08/25/2004EP1449922A2 Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
08/25/2004EP1449921A2 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides
08/25/2004EP1449918A1 Process for producing l-amino acid using escherichia
08/25/2004EP1449913A1 Gamma-glutamylcysteine-producing yeast
08/25/2004EP1449851A1 ANTI-IL13 RECEPTOR alpha 1 NEUTRALIZING ANTIBODY
08/25/2004EP1449850A1 Human cdr-grafted antibodies and antibody fragments thereof
08/25/2004EP1449849A2 Protease-resistant thrombomodulin analog
08/25/2004EP1449848A1 Method for the production of cystine-knot proteins
08/25/2004EP1449537A2 Methods for treating hypercoagulable states or acquired protein C deficiency
08/25/2004EP1448787A2 Human monoclonal antibodies to dendritic cells
08/25/2004EP1448786A2 Process for preparing insulin compounds
08/25/2004EP1448780A2 Direct targeting binding proteins
08/25/2004EP1448772A2 Methods of increasing protein expression levels
08/25/2004EP1448760A2 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry
08/25/2004EP1448602A2 Modified anti-tnf alpha antibody
08/25/2004EP1448595A1 Antimicrobial polypeptides from pseudoplectania nigrella
08/25/2004EP1448588A2 Psma antibodies and protein multimers
08/25/2004EP1448583A2 A novel g protein-coupled receptor, gave8
08/25/2004EP1221853A4 Oligodendrocyte cell cultures and methods for their preparation and use
08/25/2004EP1190257B1 Early detection of flaviviruses using the ns1 glycoprotein
08/25/2004EP0893449B1 Antitumor substance extracted from hen-of-the-woods
08/25/2004EP0830130B1 Tnf-alpha converting enzyme
08/25/2004EP0826051B1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions
08/25/2004EP0816380B1 Ocif protein and methods for the production of the same
08/25/2004EP0734444B1 Gene encoding carboxypeptidase of aspergillus niger
08/25/2004EP0724632B1 Stem cell proliferation factor
08/25/2004EP0700441B1 Multiple sclerosis virus
08/25/2004CN1524123A A soluble complex comprising a retroviral surface glycoprotein
08/25/2004CN1524092A Concatameric immunoadhesion
08/25/2004CN1524090A Modified insulin with reduced immunogenicity
08/25/2004CN1523117A Active peptide of pigeon
08/25/2004CN1523105A Serine proteinase and coded sequence thereof
08/25/2004CN1523036A Anti-coagulate protein and its coding gene and high effective expression method
08/25/2004CN1163754C Method for diagnosing a patient for chlamydia
08/25/2004CN1163612C Nucleic acid molecule coding sucrose dependent sucrose fructosyl transferase and method for producing short chain fructosyl polymer
08/25/2004CN1163607C Polypeptide with aminopeptidase activity and its coded nucleic acid
08/25/2004CN1163604C Gene 62 of attenuated varicella virus strain and method for identifying virus strain for attenuated live vaccine using the gene
08/25/2004CN1163603C Enhanced internal translation factor of eukaryotic cell and its use
08/25/2004CN1163602C Fusion protein of tubercle bacillus antigen, and its use
08/25/2004CN1163600C Process for preparing human proinsulin
08/25/2004CN1163599C Anti-GPIIB/IIIA recombination antibody
08/25/2004CN1163509C RET ligand (RetL) for stimulating neural and renal growth
08/25/2004CN1163506C Novel human cell factor and its coding sequence and use
08/25/2004CN1163150C Method for recovering isoflavone aglycone-enriching soybean protein extract
08/24/2004US6780983 Polypeptide having water channel activity and DNA sequence
08/24/2004US6780975 Long wavelength engineered fluorescent proteins
08/24/2004US6780970 Peptides for use in the treatment and prevention of diabetes, reperfusion injuries, immunological, cardiovascular and autoimune diseases
08/24/2004US6780967 Metal chelate-labelled peptides
08/24/2004US6780627 22438, 23553, 25278, and 26212 novel human sulfatases
08/24/2004US6780614 Modified factor VIII cDNA and its use for the production of factor VIII
08/24/2004US6780613 For identifying active domains and amino acid residues in polypeptides; prolactins; placental lactogens
08/24/2004US6780611 G protein coupled receptors; drug screening
08/24/2004US6780609 High bone mass gene of 1.1q13.3
08/24/2004US6780608 Comprises chimeric polypeptides with varying calcium/caffeine sensitivity; for drug screening
08/24/2004US6780607 Generation of preferential proteins in cell free system; obtain cell extract, incubate with nucleotide sequences, expose to translational organelles, recover processed proteins
08/24/2004US6780600 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
08/24/2004US6780420 Carrier protein having an adjuvant effect, immunogenic complex containing it, process for their preparation, nucleotide sequence and vaccine
08/24/2004US6780419 Isolated polypeptide comprising specified amino acid sequence or immunogenic fragment of at least 15 contiguous amino acids, which when administered to subject induces antibody or t-cell mediated immune response that recognizes polypeptide
08/24/2004US6780416 Bee venom polypeptides and methods of use thereof
08/24/2004US6780412 Protein and monoclonal antibody specific thereto
08/24/2004US6780405 Having first origin of replication conferring low copy number, conferring vector replication using dna polymerase iii, second origin of replication operably linked to first promoter and repressed by chromosome-encoded repressor, as is foreign gene
08/24/2004CA2173626C B1k chain of laminin and methods of use
08/24/2004CA2061148C Glia activating factor and its production
08/19/2004WO2004070047A1 Automatic process for protein synthesis and apparatus therefor
08/19/2004WO2004070022A2 Use of oxalate deficient aspergillus niger strains for producing a polypeptide
08/19/2004WO2004070015A2 Nematode pan and zp receptor-like sequences
08/19/2004WO2004070004A2 Rat receptor tyrosine kinase, kdr